Results 31 to 40 of about 153,607 (304)

Nanoplatforms Potentiated Ablation-Immune Synergistic Therapy through Improving Local Control and Suppressing Recurrent Metastasis

Pharmaceutics, 2023
Minimally invasive ablation has been widely applied for treatment of various solid tumors, including hepatocellular carcinoma, renal cell carcinoma, breast carcinomas, etc.
Zixuan Wei, Xiaoya Yu, Mao Huang, Liewei Wen, Cuixia Lu   +4 more
doaj   +1 more source

Purcutaneus Radiofrequency Ablation In Liver Tumor

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022
Tumor ablation is a minimally invasive approach commonly used in the treatment of liver tumors. Over the last two decades, percutaneous radiofrequency ablation (RFA) has been widely used for primary tumors and small metastases, especially in the liver ...
Budi Tulaka, Bradley Jimmy Waleleng, Luciana Rotty   +2 more
doaj   +1 more source

Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model

Molecules, 2021
Purpose: Vascular targeted photodynamic therapy (VTP) is a nonsurgical tumor ablation approach used to treat early-stage prostate cancer and may also be effective for upper tract urothelial cancer (UTUC) based on preclinical data.
Ricardo G. Alvim, Petrina Georgala, Lucas Nogueira, Alexander J. Somma, Karan Nagar, Jasmine Thomas, Laura Alvim, Amelia Riegel, Christopher Hughes, Jie Chen, Augusto B. Reis, Souhil Lebdai, Avigdor Scherz, Steven Zanganeh, Rui Gardner, Kwanghee Kim, Jonathan A. Coleman   +16 more
doaj   +1 more source

Expert Consensus for Thermal Ablation of Pulmonary Subsolid Nodules (2021 Edition)

Chinese Journal of Lung Cancer, 2021
“The Expert Group on Tumor Ablation Therapy of Chinese Medical Doctor Association, The Tumor Ablation Committee of Chinese College of Interventionalists, The Society of Tumor Ablation Therapy of Chinese Anti-Cancer Association and The Ablation Expert ...
Xin YE, Weijun FAN, Zhongmin WANG, Junjie WANG, Hui WANG, Jun WANG, Chuntang WANG, Lizhi NIU, Yong FANG, Shanzhi GU, Hui TIAN, Baodong LIU, Lou ZHONG, Yiping ZHUANG, Jiachang CHI, Xichao SUN, Nuo YANG, Zhigang WEI, Xiao LI, Xiaoguang LI, Yuliang LI, Chunhai LI, Yan LI, Xia YANG, Wuwei YANG, Po YANG, Zhengqiang YANG, Yueyong XIAO, Xiaoming SONG, Kaixian ZHANG, Shilin CHEN, Weisheng CHEN, Zhengyu LIN, Dianjie LIN, Zhiqiang MENG, Xiaojing ZHAO, Kaiwen HU, Chen LIU, Cheng LIU, Chundong GU, Dong XU, Yong HUANG, Guanghui HUANG, Zhongmin PENG, Liang DONG, Lei JIANG, Yue HAN, Qingshi ZENG, Yong JIN, Guangyan LEI, Bo ZHAI, Hailiang LI, Jie PAN, The Expert Group on Tumor Ablation Therapy of Chinese Medical Doctor Association, The Tumor Ablation Committee of Chinese College of Interventionalists, The Society of Tumor Ablation Therapy of Chinese Anti-Cancer Association, The Ablation Expert Committee of the Chinese Society of Clinical Oncology   +56 more
doaj   +1 more source

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

Frontiers in Oncology, 2023
Energy-based focal therapy (FT) uses targeted, minimally invasive procedures to destroy tumors while preserving normal tissue and function. There is strong emerging interest in understanding how systemic immunity against the tumor can occur with cancer ...
Minhan Jiang, Steven Fiering, Steven Fiering, Qi Shao   +3 more
doaj   +1 more source

Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy

Cells, 2021
Ablation therapies have emerged as an effective tool for destroying cancerous tissue, but for advanced and disseminated tumors their application remains mainly a palliative measure.
Mladen Korbelik, Tomas Hode, Samuel S. K. Lam, Wei R. Chen   +3 more
doaj   +1 more source

Novel Therapeutic Method for Unresectable Pancreatic Cancer—The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy

Current Oncology, 2021
High-intensity focused ultrasound (HIFU) is a novel advanced therapy for unresectable pancreatic cancer (PC). HIFU therapy with chemotherapy is being promoted as a novel method to control local advancement by tumor ablation.
Atsushi Sofuni, Yasutsugu Asai, Takayoshi Tsuchiya, Kentaro Ishii, Reina Tanaka, Ryosuke Tonozuka, Mitsuyoshi Honjo, Shuntaro Mukai, Kazumasa Nagai, Kenjiro Yamamoto, Yukitoshi Matsunami, Takashi Kurosawa, Hiroyuki Kojima, Toshihiro Homma, Hirohito Minami, Ryosuke Nakatsubo, Noriyuki Hirakawa, Hideaki Miyazawa, Yuichi Nagakawa, Akihiko Tsuchida, Takao Itoi   +20 more
doaj   +1 more source

Volumetric Quantitative Ablation Margins for Assessment of Ablation Completeness in Thermal Ablation of Liver Tumors

Frontiers in Oncology, 2021
BackgroundIn thermal ablation of liver tumors, complete coverage of the tumor volume by the ablation volume with a sufficient ablation margin is the most important factor for treatment success. Evaluation of ablation completeness is commonly performed by
Raluca-Maria Sandu, Iwan Paolucci, Simeon J. S. Ruiter, Raphael Sznitman, Koert P. de Jong, Jacob Freedman, Stefan Weber, Pascale Tinguely, Pascale Tinguely   +8 more
doaj   +1 more source

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]

, 2011
Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M., P. Paprottka, F.T. Kolligs, M. Rentsch, Paprottka, P., T.F. Jakobs, Kolligs, F. T., Reiser, Maximilian F., Jakobs, T. F., Ashoori, N., F. Bamberg, Bamberg, F., Trumm, C., N. Ashoori, C. Trumm, M.F. Reiser   +15 more
core   +1 more source

Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation [PDF]

, 2012
Purpose: To evaluate the efficiency of a multimodality approach consisting of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) as bridging therapy for patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver
Rentsch, M., P. Paprottka, F.T. Kolligs, Siegert, S., Kolligs, F. T., R.T. Hoffmann, Hoffmann, Ralf-Thorsten, Reiser, Maximilian F., Paprottka, Philipp M., D’Anastasi, Melvin, Jakobs, Tobias F., N. Ashoori, J.A. Al-Tubaikh, M.F. Reiser, Ashoori, Nima, M. Rentsch, Al-Tubaikh, J. A., Paprottka, P., Al-Tubaikh, Jarrah Ali, T.F. Jakobs, Kolligs, Frank T., Rentsch, Markus, Peporte, A., Hoffmann, R. T., M. D’Anastasi, Jakobs, T. F., D'Anastasi, M., Ashoori, N., Siegert, Sabine, S. Siegert, Bamberg, Fabian, F. Bamberg, Bamberg, F., A. Peporte   +33 more
core   +1 more source